Antibiotics Are Man's Greatest Invention

The Antibiotic Market Is Broken—and Won’t Fix Itself

Over the past year we’ve watched two troubling trends escalate. First, patients increasingly face—and their doctors struggle to treat—infections that do not respond to existing antibiotics. Second, major pharmaceutical companies are backing away from developing new antibiotics. Last July, Novartis became the third major pharmaceutical company in 2018 alone to announce that it would end antibiotic……

Differential effects of alkyl gallates on quorum sensing in Pseudomonas aeruginosa

Antibiotics and Human Health Care

The more they are used, the less effective antibiotics become. When people take antibiotics, drug-resistant bacteria survive and can be passed to other individuals….

Anti-psychotic drugs block meningococcal virulence

Experts Identify Key Ways to Strengthen Antibiotic Stewardship Programs

Reducing inappropriate antibiotic use in hospitals and other health care settings is essential to protect patients from alarming types of antibiotic-resistant bacteria, commonly known as superbugs….

New tools for new treatments

Changes to Quality Measures Could Improve Understanding of Antibiotic Use

The more antibiotics are used, the less effective they become—which is why ensuring appropriate use is essential to slowing the emergence of multidrug-resistant bacteria. Although there has been encouraging progress in recent years in the collection and availability of data regarding antibiotic use in human health care, inappropriate use persists, and enhanced information about antibiotic……

Antarctic Streptomyces fildesensis So13.3 strain as a promising source for antimicrobials discovery

Novartis Shares 2 New Datasets With SPARK, Pew’s Antibiotic Discovery Tool

Following an earlier contribution of data by Novartis to The Pew Charitable Trust’s Shared Platform for Antibiotic Research and Knowledge (SPARK), a cloud-based interactive antibiotic discovery tool, the company recently shared two additional datasets from its discontinued antibiotic discovery program….